{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:27:08Z","timestamp":1792621628854,"version":"4.5.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.7759\/cureus.94508","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T03:35:32Z","timestamp":1760412932000},"source":"Crossref","is-referenced-by-count":1,"title":["Gene Therapy and Epigenetic Modulation in Chronic Pain: A Future Without Opioids?"],"prefix":"10.7759","author":[{"given":"Courage O","family":"Idahor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam A","family":"Okorie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mokobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prize","family":"Erhuanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndidiamaka","family":"Ogbonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olamide","family":"Ogunfuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovie M","family":"Etoroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itua J","family":"Abhulimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekene","family":"Chinedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: a challenge for biomedicine","volume":"196","author":"Engel GL","year":"1977","unstructured":"Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977, 196:129-36. 10.1126\/science.847460","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1097\/00002508-200006001-00002","article-title":"Pain and suffering","volume":"16","author":"Loeser JD","year":"2000","unstructured":"Loeser JD. Pain and suffering. Clin J Pain. 2000, 16:2-6.","journal-title":"Clin J Pain"},{"key":"ref3","article-title":"Behavioral Methods for Chronic Pain and Illness","author":"Fordyce WE","year":"1976","unstructured":"Fordyce WE. Behavioral Methods for Chronic Pain and Illness. Mosby, St. Louis, MO; 1976."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.133.4.581","article-title":"The biopsychosocial approach to chronic pain: scientific advances and future directions","volume":"133","author":"Gatchel RJ","year":"2007","unstructured":"Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007, 133:581-624. 10.1037\/0033-2909.133.4.581","journal-title":"Psychol Bull"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.70.3.678","article-title":"Psychological factors in chronic pain: evolution and revolution","volume":"70","author":"Turk DC","year":"2002","unstructured":"Turk DC, Okifuji A. Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol. 2002, 70:678-90. 10.1037\/0022-006X.70.3.678","journal-title":"J Consult Clin Psychol"},{"key":"ref6","article-title":"Manage Your Pain: Practical and Positive Ways of Adapting to Chronic Pain","author":"Nicholas M","year":"2012","unstructured":"Nicholas M. Manage Your Pain: Practical and Positive Ways of Adapting to Chronic Pain. Goldberg DS, McGee SJ (ed): Souvenir Press, London, UK; 2012."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nn942","article-title":"Can we conquer pain?","volume":"5","author":"Scholz J","year":"2002","unstructured":"Scholz J, Woolf CJ. Can we conquer pain?. Nat Neurosci. 2002, 5:1062-7. 10.1038\/nn942","journal-title":"Nat Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik H","year":"2006","unstructured":"Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006, 10:287-333. 10.1016\/j.ejpain.2005.06.009","journal-title":"Eur J Pain"},{"key":"ref9","article-title":"Wall & Melzack's Textbook of Pain","author":"McMahon SB","year":"2025","unstructured":"McMahon SB, Koltzenburg M, Tracey I, Turk D. Wall & Melzack's Textbook of Pain. Saunder, Philadelphia, PA; 2025."},{"key":"ref10","article-title":"Functional restoration for spinal disorders: the sports medicine approach","author":"Mayer TG","year":"2004","unstructured":"Mayer TG, Gatchel RJ. Functional restoration for spinal disorders: the sports medicine approach. The Adult and Paediatric Spine. Frymoyer JW, Wiesel SW (ed): Lippincott Williams & Wilkins, Philadelphia, PA; 2004. 1:323."},{"key":"ref11","article-title":"Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids","volume":"11","author":"Manchikanti L","year":"2008","unstructured":"Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008, 11:S63-88.","journal-title":"Pain Physician"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2014.12.001","article-title":"Opioid therapy in chronic pain","volume":"26","author":"Ballantyne JC","year":"2015","unstructured":"Ballantyne JC. Opioid therapy in chronic pain. Phys Med Rehabil Clin N Am. 2015, 26:201-18. 10.1016\/j.pmr.2014.12.001","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal. pone.0281760","article-title":"Finding help and hope in a peer-led reentry service hub near a detention centre: a process evaluation","volume":"2","author":"McLuhan A","year":"2023","unstructured":"McLuhan A, Hahmann T, Mejia-Lancheros C, Hamilton-Wright, Tacchini G, Matheson F. Finding help and hope in a peer-led reentry service hub near a detention centre: a process evaluation. Plos One. 2023, 2:817-60. 10.1371\/journal. pone.0281760","journal-title":"Plos One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi LJ","year":"2006","unstructured":"Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006, 15:618-27. 10.1002\/pds.1276","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain--misconceptions and mitigation strategies","volume":"374","author":"Volkow ND","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain--misconceptions and mitigation strategies. N Engl J Med. 2016, 374:1253-63. 10.1056\/NEJMra1507771","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.01.012","article-title":"Chronic pain: emerging evidence for the involvement of epigenetics","volume":"73","author":"Denk F","year":"2012","unstructured":"Denk F, McMahon SB. Chronic pain: emerging evidence for the involvement of epigenetics. Neuron. 2012, 73:435-44. 10.1016\/j.neuron.2012.01.012","journal-title":"Neuron"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere A","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009, 10:895-926. 10.1016\/j.jpain.2009.06.012","journal-title":"J Pain"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2010.06.004","article-title":"Epigenetics in pain and analgesia: an imminent research field","volume":"15","author":"Doehring A","year":"2011","unstructured":"Doehring A, Geisslinger G, L\u00f6tsch J. Epigenetics in pain and analgesia: an imminent research field. Eur J Pain. 2011, 15:11-6. 10.1016\/j.ejpain.2010.06.004","journal-title":"Eur J Pain"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.12.021","article-title":"Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury","volume":"166","author":"Uchida H","year":"2010","unstructured":"Uchida H, Sasaki K, Ma L, Ueda H. Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury. Neuroscience. 2010, 166:1-4. 10.1016\/j.neuroscience.2009.12.021","journal-title":"Neuroscience"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2217\/epi.14.75","article-title":"Epigenetic regulation of chronic pain","volume":"7","author":"Liang L","year":"2015","unstructured":"Liang L, Lutz BM, Bekker A, Tao YX. Epigenetic regulation of chronic pain. Epigenomics. 2015, 7:235-45. 10.2217\/epi.14.75","journal-title":"Epigenomics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22446","article-title":"Gene therapy for pain: results of a phase I clinical trial","volume":"70","author":"Fink DJ","year":"2011","unstructured":"Fink DJ, Wechuck J, Mata M, Glorioso JC, Goss J, Krisky D, Wolfe D. Gene therapy for pain: results of a phase I clinical trial. Ann Neurol. 2011, 70:207-12. 10.1002\/ana.22446","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2015.00063","article-title":"Virus-mediated knockdown of Nav1.3 in dorsal root ganglia of STZ-induced diabetic rats alleviates tactile allodynia","volume":"21","author":"Tan AM","year":"2015","unstructured":"Tan AM, Samad OA, Dib-Hajj SD, Waxman SG. Virus-mediated knockdown of Nav1.3 in dorsal root ganglia of STZ-induced diabetic rats alleviates tactile allodynia. Mol Med. 2015, 21:544-52. 10.2119\/molmed.2015.00063","journal-title":"Mol Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup NB","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al.. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015, 14:162-73. 10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.02.018","article-title":"Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations","volume":"149","author":"Dworkin RH","year":"2010","unstructured":"Dworkin RH, Turk DC, Peirce-Sandner S, et al.. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain. 2010, 149:177-93. 10.1016\/j.pain.2010.02.018","journal-title":"Pain"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: an update","volume":"20","author":"Ginn SL","year":"2018","unstructured":"Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR. Gene therapy clinical trials worldwide to 2017: an update. J Gene Med. 2018, 20:e3015. 10.1002\/jgm.3015","journal-title":"J Gene Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): where are we, and how did we get here?","volume":"6","author":"Keeler AM","year":"2019","unstructured":"Keeler AM, Flotte TR. Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): where are we, and how did we get here?. Annu Rev Virol. 2019, 6:601-21. 10.1146\/annurev-virology-092818-015530","journal-title":"Annu Rev Virol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.213","article-title":"Herpes vector-mediated gene transfer in the treatment of chronic pain","volume":"17","author":"Glorioso JC","year":"2009","unstructured":"Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther. 2009, 17:13-8. 10.1038\/mt.2008.213","journal-title":"Mol Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini L","year":"2015","unstructured":"Naldini L. Gene therapy returns to centre stage. Nature. 2015, 526:351-60. 10.1038\/nature15818","journal-title":"Nature"},{"key":"ref29","article-title":"Non viral vectors in gene therapy - an overview","volume":"4","author":"Ramamoorth M","year":"2015","unstructured":"Ramamoorth M. Non viral vectors in gene therapy - an overview. J Clin Diagn Res. 2015, 4:26-8.","journal-title":"J Clin Diagn Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903435340","article-title":"Targeting voltage-gated sodium channels for pain therapy","volume":"19","author":"Clare JJ","year":"2010","unstructured":"Clare JJ. Targeting voltage-gated sodium channels for pain therapy. Expert Opin Investig Drugs. 2010, 19:45-62. 10.1517\/13543780903435340","journal-title":"Expert Opin Investig Drugs"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001119","article-title":"NaV1.7 and pain: contribution of peripheral nerves","volume":"159","author":"Hoffmann T","year":"2018","unstructured":"Hoffmann T, Sharon O, Wittmann J, et al.. NaV1.7 and pain: contribution of peripheral nerves. Pain. 2018, 159:496-506. 10.1097\/j.pain.0000000000001119","journal-title":"Pain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox JJ","year":"2006","unstructured":"Cox JJ, Reimann F, Nicholas AK, et al.. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006, 444:894-8. 10.1038\/nature05413","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-016-0215-0","article-title":"shRNA mediated knockdown of Nav1.7 in rat dorsal root ganglion attenuates pain following burn injury","volume":"16","author":"Cai W","year":"2016","unstructured":"Cai W, Cao J, Ren X, Qiao L, Chen X, Li M, Zang W. shRNA mediated knockdown of Nav1.7 in rat dorsal root ganglion attenuates pain following burn injury. BMC Anesthesiol. 2016, 16:59. 10.1186\/s12871-016-0215-0","journal-title":"BMC Anesthesiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2013.01.019","article-title":"Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels","volume":"1828","author":"Adams DJ","year":"2013","unstructured":"Adams DJ, Berecki G. Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels. Biochim Biophys Acta. 2013, 1828:1619-28. 10.1016\/j.bbamem.2013.01.019","journal-title":"Biochim Biophys Acta"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708003105","article-title":"Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain","volume":"105","author":"Storek B","year":"2008","unstructured":"Storek B, Reinhardt M, Wang C, et al.. Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain. Proc Natl Acad Sci U S A. 2008, 105:1055-60. 10.1073\/pnas.0708003105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005544","article-title":"Proenkephalin, an opioid system surrogate, as a novel comprehensive renal marker in heart failure","volume":"12","author":"Emmens JE","year":"2019","unstructured":"Emmens JE, Ter Maaten JM, Damman K, et al.. Proenkephalin, an opioid system surrogate, as a novel comprehensive renal marker in heart failure. Circ Heart Fail. 2019, 12:e005544. 10.1161\/CIRCHEARTFAILURE.118.005544","journal-title":"Circ Heart Fail"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2012.00462.x","article-title":"Spinal interleukin-10 therapy to treat peripheral neuropathic pain","volume":"15","author":"Milligan ED","year":"2012","unstructured":"Milligan ED, Penzkover KR, Soderquist RG, Mahoney MJ. Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation. 2012, 15:520-6. 10.1111\/j.1525-1403.2012.00462.x","journal-title":"Neuromodulation"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(00)02050-3","article-title":"Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120","volume":"861","author":"Milligan ED","year":"2000","unstructured":"Milligan ED, Mehmert KK, Hinde JL, et al.. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 2000, 861:105-16. 10.1016\/s0006-8993(00)02050-3","journal-title":"Brain Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709250104","article-title":"Chemokines and the pathophysiology of neuropathic pain","volume":"104","author":"White FA","year":"2007","unstructured":"White FA, Jung H, Miller RJ. Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A. 2007, 104:20151-8. 10.1073\/pnas.0709250104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300755","article-title":"Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications","volume":"5","author":"Krisky DM","year":"1998","unstructured":"Krisky DM, Marconi PC, Oligino TJ, et al.. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther. 1998, 5:1517-30. 10.1038\/sj.gt.3300755","journal-title":"Gene Ther"},{"key":"ref41","article-title":"Gene therapy","volume":"381","author":"High KA","year":"2019","unstructured":"High KA, Roncarolo MG. Gene therapy. N Engl J Med. 2019, 381:455-64.","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Ho Kim S","year":"1992","unstructured":"Ho Kim S, Mo Chung J. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992, 50:355-63. 10.1016\/0304-3959(92)90041-9","journal-title":"Pain"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101756","article-title":"Gene therapy for chronic pain management","volume":"5","author":"Li YZ","year":"2024","unstructured":"Li YZ, Ji RR. Gene therapy for chronic pain management. Cell Rep Med. 2024, 5:101756. 10.1016\/j.xcrm.2024.101756","journal-title":"Cell Rep Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.06.018","article-title":"AAV-mediated combination gene therapy for neuropathic pain: GAD65, GDNF, and IL-10","volume":"18","author":"Kim D","year":"2020","unstructured":"Kim D, Kim KR, Kwon Y, et al.. AAV-mediated combination gene therapy for neuropathic pain: GAD65, GDNF, and IL-10. Mol Ther Methods Clin Dev. 2020, 18:473-83. 10.1016\/j.omtm.2020.06.018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup NB","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021, 101:259-301. 10.1152\/physrev.00045.2019","journal-title":"Physiol Rev"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.140","article-title":"Epigenetic regulation and chromatin remodeling in learning and memory","volume":"49","author":"Kim S","year":"2017","unstructured":"Kim S, Kaang BK. Epigenetic regulation and chromatin remodeling in learning and memory. Exp Mol Med. 2017, 49:e281. 10.1038\/emm.2016.140","journal-title":"Exp Mol Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00794-7","article-title":"Neuromodulation for chronic pain","volume":"397","author":"Knotkova H","year":"2021","unstructured":"Knotkova H, Hamani C, Sivanesan E, Le Beuffe MF, Moon JY, Cohen SP, Huntoon MA. Neuromodulation for chronic pain. Lancet. 2021, 397:2111-24. 10.1016\/S0140-6736(21)00794-7","journal-title":"Lancet"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnw078","article-title":"Patients' perspectives on tapering of chronic opioid therapy: a qualitative study","volume":"17","author":"Frank JW","year":"2016","unstructured":"Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' perspectives on tapering of chronic opioid therapy: a qualitative study. Pain Med. 2016, 17:1838-47. 10.1093\/pm\/pnw078","journal-title":"Pain Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2230","article-title":"Overcoming obstacles to developing new analgesics","volume":"16","author":"Woolf CJ","year":"2010","unstructured":"Woolf CJ. Overcoming obstacles to developing new analgesics. Nat Med. 2010, 16:1241-7. 10.1038\/nm.2230","journal-title":"Nat Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird A","year":"2007","unstructured":"Bird A. Perceptions of epigenetics. Nature. 2007, 447:396-8. 10.1038\/nature05913","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch R","year":"2003","unstructured":"Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003, 33:245-54. 10.1038\/ng1089","journal-title":"Nat Genet"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-061008-103102","article-title":"Epigenetics, DNA methylation, and chromatin modifying drugs","volume":"49","author":"Szyf M","year":"2009","unstructured":"Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol. 2009, 49:243-63. 10.1146\/annurev-pharmtox-061008-103102","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore LD","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013, 38:23-38. 10.1038\/npp.2012.112","journal-title":"Neuropsychopharmacology"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1177\/0022034510378683","article-title":"Epigenetic mechanisms in inflammation","volume":"90","author":"Bayarsaihan D","year":"2011","unstructured":"Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res. 2011, 90:9-17.","journal-title":"J Dent Res"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister AJ","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21:381-95. 10.1038\/cr.2011.22","journal-title":"Cell Res"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis CD","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016, 17:487-500. 10.1038\/nrg.2016.59","journal-title":"Nat Rev Genet"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland M","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009, 10:32-42. 10.1038\/nrg2485","journal-title":"Nat Rev Genet"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides T","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007, 128:693-705. 10.1016\/j.cell.2007.02.005","journal-title":"Cell"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer EL","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012, 13:343-57. 10.1038\/nrg3173","journal-title":"Nat Rev Genet"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller M","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011, 12:861-74. 10.1038\/nrg3074","journal-title":"Nat Rev Genet"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.10.016","article-title":"The emerging field of pain epigenetics","volume":"154","author":"Stone LS","year":"2013","unstructured":"Stone LS, Szyf M. The emerging field of pain epigenetics. Pain. 2013, 154:1-2. 10.1016\/j.pain.2012.10.016","journal-title":"Pain"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2019.10.007","article-title":"The interaction between stress and chronic pain through the lens of threat learning","volume":"107","author":"Timmers I","year":"2019","unstructured":"Timmers I, Quaedflieg CW, Hsu C, Heathcote LC, Rovnaghi CR, Simons LE. The interaction between stress and chronic pain through the lens of threat learning. Neurosci Biobehav Rev. 2019, 107:641-55. 10.1016\/j.neubiorev.2019.10.007","journal-title":"Neurosci Biobehav Rev"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1126\/science.1239403","article-title":"Constitutive \u03bc-opioid receptor activity leads to long-term endogenous analgesia and dependence","volume":"341","author":"Corder G","year":"2013","unstructured":"Corder G, Doolen S, Donahue RR, et al.. Constitutive \u03bc-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science. 2013, 341:1394-9. 10.1126\/science.1239403","journal-title":"Science"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.063","article-title":"Persistent alterations in microglial enhancers in a model of chronic pain","volume":"15","author":"Denk F","year":"2016","unstructured":"Denk F, Crow M, Didangelos A, Lopes DM, McMahon SB. Persistent alterations in microglial enhancers in a model of chronic pain. Cell Rep. 2016, 15:1771-81. 10.1016\/j.celrep.2016.04.063","journal-title":"Cell Rep"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18562-x","article-title":"Author correction: DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons","volume":"11","author":"Zhao JY","year":"2020","unstructured":"Zhao JY, Liang L, Gu X, et al.. Author correction: DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons. Nat Commun. 2020, 11:4696. 10.1038\/s41467-020-18562-x","journal-title":"Nat Commun"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23802","article-title":"Psychological stress in early life as a predisposing factor for the development of chronic pain: clinical and preclinical evidence and neurobiological mechanisms","volume":"95","author":"Burke NN","year":"2017","unstructured":"Burke NN, Finn DP, McGuire BE, Roche M. Psychological stress in early life as a predisposing factor for the development of chronic pain: clinical and preclinical evidence and neurobiological mechanisms. J Neurosci Res. 2017, 95:1257-70. 10.1002\/jnr.23802","journal-title":"J Neurosci Res"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.01.009","article-title":"Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications","volume":"25","author":"Szyf M","year":"2015","unstructured":"Szyf M. Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications. Eur Neuropsychopharmacol. 2015, 25:682-702. 10.1016\/j.euroneuro.2014.01.009","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3494-14.2015","article-title":"Activation of corticostriatal circuitry relieves chronic neuropathic pain","volume":"35","author":"Lee M","year":"2015","unstructured":"Lee M, Manders TR, Eberle SE, et al.. Activation of corticostriatal circuitry relieves chronic neuropathic pain. J Neurosci. 2015, 35:5247-59. 10.1523\/JNEUROSCI.3494-14.2015","journal-title":"J Neurosci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.05.021","article-title":"HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain","volume":"154","author":"Denk F","year":"2013","unstructured":"Denk F, Huang W, Sidders B, et al.. HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain. Pain. 2013, 154:1668-79. 10.1016\/j.pain.2013.05.021","journal-title":"Pain"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(06)61013-3","article-title":"Sodium channel expression and the molecular pathophysiology of pain after SCI","volume":"161","author":"Hains BC","year":"2007","unstructured":"Hains BC, Waxman SG. Sodium channel expression and the molecular pathophysiology of pain after SCI. Prog Brain Res. 2007, 161:195-203. 10.1016\/S0079-6123(06)61013-3","journal-title":"Prog Brain Res"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1980-10.2010","article-title":"Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds","volume":"30","author":"Zhao J","year":"2010","unstructured":"Zhao J, Lee MC, Momin A, et al.. Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J Neurosci. 2010, 30:10860-71. 10.1523\/JNEUROSCI.1980-10.2010","journal-title":"J Neurosci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.06.027","article-title":"Epigenetic mechanisms of opioid addiction","volume":"87","author":"Browne CJ","year":"2020","unstructured":"Browne CJ, Godino A, Salery M, Nestler EJ. Epigenetic mechanisms of opioid addiction. Biol Psychiatry. 2020, 87:22-33. 10.1016\/j.biopsych.2019.06.027","journal-title":"Biol Psychiatry"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-6-51","article-title":"Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia","volume":"6","author":"Bai G","year":"2010","unstructured":"Bai G, Wei D, Zou S, Ren K, Dubner R. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain. 2010, 6:51. 10.1186\/1744-8069-6-51","journal-title":"Mol Pain"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2442","article-title":"Epigenetic suppression of GAD65 expression mediates persistent pain","volume":"17","author":"Zhang Z","year":"2011","unstructured":"Zhang Z, Cai YQ, Zou F, Bie B, Pan ZZ. Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med. 2011, 17:1448-55. 10.1038\/nm.2442","journal-title":"Nat Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2014.05.006","article-title":"Noncoding RNAs: key molecules in understanding and treating pain","volume":"20","author":"Bali KK","year":"2014","unstructured":"Bali KK, Kuner R. Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med. 2014, 20:437-48. 10.1016\/j.molmed.2014.05.006","journal-title":"Trends Mol Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-143","article-title":"MicroRNA-124 as a novel treatment for persistent hyperalgesia","volume":"9","author":"Willemen HL","year":"2012","unstructured":"Willemen HL, Huo XJ, Mao-Ying QL, Zijlstra J, Heijnen CJ, Kavelaars A. MicroRNA-124 as a novel treatment for persistent hyperalgesia. J Neuroinflammation. 2012, 9:143. 10.1186\/1742-2094-9-143","journal-title":"J Neuroinflammation"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00175","article-title":"The role of long noncoding RNAs in central nervous system and neurodegenerative diseases","volume":"12","author":"Wei CW","year":"2018","unstructured":"Wei CW, Luo T, Zou SS, Wu AS. The role of long noncoding RNAs in central nervous system and neurodegenerative diseases. Front Behav Neurosci. 2018, 12:175. 10.3389\/fnbeh.2018.00175","journal-title":"Front Behav Neurosci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01969.x","article-title":"Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing","volume":"86","author":"Svensson CI","year":"2003","unstructured":"Svensson CI, Marsala M, Westerlund A, et al.. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem. 2003, 86:1534-44. 10.1046\/j.1471-4159.2003.01969.x","journal-title":"J Neurochem"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-020-00166-4","article-title":"Neuropathic pain dysregulates gene expression of the forebrain opioid and dopamine systems","volume":"37","author":"Wawrzczak-Bargie\u0142a A","year":"2020","unstructured":"Wawrzczak-Bargie\u0142a A, Zi\u00f3\u0142kowska B, Piotrowska A, et al.. Neuropathic pain dysregulates gene expression of the forebrain opioid and dopamine systems. Neurotox Res. 2020, 37:800-14. 10.1007\/s12640-020-00166-4","journal-title":"Neurotox Res"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-022-00199-6","article-title":"Neuroplasticity related to chronic pain and its modulation by microglia","volume":"42","author":"Hiraga SI","year":"2022","unstructured":"Hiraga SI, Itokazu T, Nishibe M, Yamashita T. Neuroplasticity related to chronic pain and its modulation by microglia. Inflamm Regen. 2022, 42:15. 10.1186\/s41232-022-00199-6","journal-title":"Inflamm Regen"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1177\/1073858409360822","article-title":"Glial cells and chronic pain","volume":"16","author":"Gosselin RD","year":"2010","unstructured":"Gosselin RD, Suter MR, Ji RR, Decosterd I. Glial cells and chronic pain. Neuroscientist. 2010, 16:519-31. 10.1177\/1073858409360822","journal-title":"Neuroscientist"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14745","article-title":"Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: from epigenetic to selective drugs","volume":"30","author":"Zhang W","year":"2024","unstructured":"Zhang W, Jiao B, Yu S, Zhang C, Zhang K, Liu B, Zhang X. Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: from epigenetic to selective drugs. CNS Neurosci Ther. 2024, 30:e14745. 10.1111\/cns.14745","journal-title":"CNS Neurosci Ther"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3628","article-title":"Pain vulnerability: a neurobiological perspective","volume":"17","author":"Denk F","year":"2014","unstructured":"Denk F, McMahon SB, Tracey I. Pain vulnerability: a neurobiological perspective. Nat Neurosci. 2014, 17:192-200. 10.1038\/nn.3628","journal-title":"Nat Neurosci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.03.007","article-title":"Resilience to stress and resilience to pain: lessons from molecular neurobiology and genetics","volume":"26","author":"Nestler EJ","year":"2020","unstructured":"Nestler EJ, Waxman SG. Resilience to stress and resilience to pain: lessons from molecular neurobiology and genetics. Trends Mol Med. 2020, 26:924-35. 10.1016\/j.molmed.2020.03.007","journal-title":"Trends Mol Med"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1159\/000445875","article-title":"Rapid down-regulation of glucocorticoid receptor gene expression in the dentate gyrus after acute stress in vivo: role of DNA methylation and microRNA activity","volume":"104","author":"Mifsud KR","year":"2017","unstructured":"Mifsud KR, Saunderson EA, Spiers H, Carter SD, Trollope AF, Mill J, Reul JM. Rapid down-regulation of glucocorticoid receptor gene expression in the dentate gyrus after acute stress in vivo: role of DNA methylation and microRNA activity. Neuroendocrinology. 2017, 104:157-69. 10.1159\/000445875","journal-title":"Neuroendocrinology"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01488-x","article-title":"HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain","volume":"32","author":"Manengu C","year":"2024","unstructured":"Manengu C, Zhu CH, Zhang GD, et al.. HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain. Inflammopharmacology. 2024, 32:2153-75. 10.1007\/s10787-024-01488-x","journal-title":"Inflammopharmacology"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1072651","article-title":"Recent progress in DNA methyltransferase inhibitors as anticancer agents","volume":"13","author":"Zhang Z","year":"2022","unstructured":"Zhang Z, Wang G, Li Y, et al.. Recent progress in DNA methyltransferase inhibitors as anticancer agents. Front Pharmacol. 2022, 13:1072651. 10.3389\/fphar.2022.1072651","journal-title":"Front Pharmacol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.054346","article-title":"Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain","volume":"75","author":"Chiechio S","year":"2009","unstructured":"Chiechio S, Zammataro M, Morales ME, et al.. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol. 2009, 75:1014-20. 10.1124\/mol.108.054346","journal-title":"Mol Pharmacol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S132691","article-title":"DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion","volume":"10","author":"Chidambaran V","year":"2017","unstructured":"Chidambaran V, Zhang X, Martin LJ, et al.. DNA methylation at the mu-1 opioid receptor gene (OPRM1) promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion. Pharmgenomics Pers Med. 2017, 10:157-68. 10.2147\/PGPM.S132691","journal-title":"Pharmgenomics Pers Med"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.6.15905","article-title":"Methylation, memory and addiction","volume":"6","author":"Bali P","year":"2011","unstructured":"Bali P, Im HI, Kenny PJ. Methylation, memory and addiction. Epigenetics. 2011, 6:671-4. 10.4161\/epi.6.6.15905","journal-title":"Epigenetics"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00193","article-title":"An updated role of microRNA-124 in central nervous system disorders: a review","volume":"9","author":"Sun Y","year":"2015","unstructured":"Sun Y, Luo ZM, Guo XM, Su DF, Liu X. An updated role of microRNA-124 in central nervous system disorders: a review. Front Cell Neurosci. 2015, 9:193. 10.3389\/fncel.2015.00193","journal-title":"Front Cell Neurosci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.2008.951251","article-title":"Histone modifications and nuclear architecture: a review","volume":"56","author":"B\u00e1rtov\u00e1 E","year":"2008","unstructured":"B\u00e1rtov\u00e1 E, Krejc\u00ed J, Harnicarov\u00e1 A, Galiov\u00e1 G, Kozubek S. Histone modifications and nuclear architecture: a review. J Histochem Cytochem. 2008, 56:711-21. 10.1369\/jhc.2008.951251","journal-title":"J Histochem Cytochem"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain","volume":"100","author":"Chen G","year":"2018","unstructured":"Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018, 100:1292-311. 10.1016\/j.neuron.2018.11.009","journal-title":"Neuron"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/795784","article-title":"Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia","volume":"2013","author":"Menzies V","year":"2013","unstructured":"Menzies V, Lyon DE, Archer KJ, et al.. Epigenetic alterations and an increased frequency of micronuclei in women with fibromyalgia. Nurs Res Pract. 2013, 2013:795784. 10.1155\/2013\/795784","journal-title":"Nurs Res Pract"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.025","article-title":"In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation","volume":"171","author":"Liao HK","year":"2017","unstructured":"Liao HK, Hatanaka F, Araoka T, et al.. In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation. Cell. 2017, 171:1495-1507.e15. 10.1016\/j.cell.2017.10.025","journal-title":"Cell"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2010.12.005","article-title":"A twin approach to unraveling epigenetics","volume":"27","author":"Bell JT","year":"2011","unstructured":"Bell JT, Spector TD. A twin approach to unraveling epigenetics. Trends Genet. 2011, 27:116-25. 10.1016\/j.tig.2010.12.005","journal-title":"Trends Genet"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29353","article-title":"Epigenetics and pain: new insights to an old problem","volume":"14","author":"Nirvanie-Persaud L","year":"2022","unstructured":"Nirvanie-Persaud L, Millis RM. Epigenetics and pain: new insights to an old problem. Cureus. 2022, 14:e29353. 10.7759\/cureus.29353","journal-title":"Cureus"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00220","article-title":"The potential of epigenetic therapies in neurodegenerative diseases","volume":"5","author":"Copped\u00e8 F","year":"2014","unstructured":"Copped\u00e8 F. The potential of epigenetic therapies in neurodegenerative diseases. Front Genet. 2014, 5:220. 10.3389\/fgene.2014.00220","journal-title":"Front Genet"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2008.06.004","article-title":"Epigenetic mechanisms in drug addiction","volume":"14","author":"Renthal W","year":"2008","unstructured":"Renthal W, Nestler EJ. Epigenetic mechanisms in drug addiction. Trends Mol Med. 2008, 14:341-50. 10.1016\/j.molmed.2008.06.004","journal-title":"Trends Mol Med"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1177\/17448069211056767","article-title":"Epigenetic modifications in neuropathic pain","volume":"17","author":"Luo D","year":"2021","unstructured":"Luo D, Li X, Tang S, et al.. Epigenetic modifications in neuropathic pain. Mol Pain. 2021, 17:17448069211056767. 10.1177\/17448069211056767","journal-title":"Mol Pain"},{"key":"ref101","unstructured":"Low tolerance for pain? The reason may be in your genes. (2014). Accessed. May 14, 2025: https:\/\/www.aan.com\/PressRoom\/Home\/PressRelease\/1269."},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.3390\/genes12081226","article-title":"Epigenetic alterations in prescription opioid misuse: new strategies for precision pain management","volume":"12","author":"Gerra MC","year":"2021","unstructured":"Gerra MC, Dallabona C, Arendt-Nielsen L. Epigenetic alterations in prescription opioid misuse: new strategies for precision pain management. Genes (Basel). 2021, 12:26-8. 10.3390\/genes12081226","journal-title":"Genes (Basel)"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1038\/srep19615","article-title":"Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells","volume":"6","author":"Massart R","year":"2016","unstructured":"Massart R, Dymov S, Millecamps M, et al.. Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells. Sci Rep. 2016, 6:19615. 10.1038\/srep19615","journal-title":"Sci Rep"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158324","article-title":"Epigenetic landscapes of pain: DNA methylation dynamics in chronic pain","volume":"25","author":"Xiong HY","year":"2024","unstructured":"Xiong HY, Wyns A, Campenhout JV, et al.. Epigenetic landscapes of pain: DNA methylation dynamics in chronic pain. Int J Mol Sci. 2024, 25:23-5. 10.3390\/ijms25158324","journal-title":"Int J Mol Sci"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.5056\/jnm.2013.19.1.94","article-title":"Opioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review","volume":"19","author":"Farmer AD","year":"2013","unstructured":"Farmer AD, Ferdinand E, Aziz Q. Opioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review. J Neurogastroenterol Motil. 2013, 19:94-8. 10.5056\/jnm.2013.19.1.94","journal-title":"J Neurogastroenterol Motil"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2016-0005","article-title":"Pharmacogenomics in pain treatment","volume":"31","author":"Peir\u00f3 AM","year":"2016","unstructured":"Peir\u00f3 AM, Planelles B, Juhasz G, et al.. Pharmacogenomics in pain treatment. Drug Metab Pers Ther. 2016, 31:131-42. 10.1515\/dmpt-2016-0005","journal-title":"Drug Metab Pers Ther"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S36619","article-title":"Herpes simplex virus-based nerve targeting gene therapy in pain management","volume":"7","author":"Goss JR","year":"2014","unstructured":"Goss JR, Krisky D, Wechuck J, Wolfe D. Herpes simplex virus-based nerve targeting gene therapy in pain management. J Pain Res. 2014, 7:71-9. 10.2147\/JPR.S36619","journal-title":"J Pain Res"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1177\/1744806916641950","article-title":"Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure","volume":"12","author":"Sahbaie P","year":"2016","unstructured":"Sahbaie P, Liang DY, Shi XY, Sun Y, Clark JD. Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure. Mol Pain. 2016, 12:14-6. 10.1177\/1744806916641950","journal-title":"Mol Pain"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.05.012","article-title":"Epigenetic regulation of persistent pain","volume":"165","author":"Bai G","year":"2015","unstructured":"Bai G, Ren K, Dubner R. Epigenetic regulation of persistent pain. Transl Res. 2015, 165:177-99. 10.1016\/j.trsl.2014.05.012","journal-title":"Transl Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws330","article-title":"Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain","volume":"136","author":"Imai S","year":"2013","unstructured":"Imai S, Ikegami D, Yamashita A, et al.. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. Brain. 2013, 136:828-43. 10.1093\/brain\/aws330","journal-title":"Brain"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087305","article-title":"Altered brain expression of DNA methylation and hydroxymethylation epigenetic enzymes in a rat model of neuropathic pain","volume":"24","author":"Rodrigues D","year":"2023","unstructured":"Rodrigues D, Monteiro C, Cardoso-Cruz H, Galhardo V. Altered brain expression of DNA methylation and hydroxymethylation epigenetic enzymes in a rat model of neuropathic pain. Int J Mol Sci. 2023, 24:23-5. 10.3390\/ijms24087305","journal-title":"Int J Mol Sci"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.08.082","article-title":"Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells","volume":"143","author":"Balasubramaniyan V","year":"2006","unstructured":"Balasubramaniyan V, Boddeke E, Bakels R, K\u00fcst B, Kooistra S, Veneman A, Copray S. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience. 2006, 143:939-51. 10.1016\/j.neuroscience.2006.08.082","journal-title":"Neuroscience"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2011.01340.x","article-title":"Pain, analgesia and genetics","volume":"63","author":"Muralidharan A","year":"2011","unstructured":"Muralidharan A, Smith MT. Pain, analgesia and genetics. J Pharm Pharmacol. 2011, 63:1387-400. 10.1111\/j.2042-7158.2011.01340.x","journal-title":"J Pharm Pharmacol"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.94","article-title":"Epigenetics of drug abuse: predisposition or response","volume":"13","author":"Nielsen DA","year":"2012","unstructured":"Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 2012, 13:1149-60. 10.2217\/pgs.12.94","journal-title":"Pharmacogenomics"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3978","article-title":"Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade","volume":"21","author":"Xu ZZ","year":"2015","unstructured":"Xu ZZ, Kim YH, Bang S, et al.. Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade. Nat Med. 2015, 21:1326-31. 10.1038\/nm.3978","journal-title":"Nat Med"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2006.197","article-title":"Gene therapy and chronic pain","volume":"6","author":"Cope DK","year":"2006","unstructured":"Cope DK, Lariviere WR. Gene therapy and chronic pain. ScientificWorldJournal. 2006, 6:1066-74. 10.1100\/tsw.2006.197","journal-title":"ScientificWorldJournal"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002439","article-title":"Dorsal root ganglion stimulation for treatment of central poststroke pain in the lower extremity after medullary infarction","volume":"162","author":"Kretzschmar M","year":"2021","unstructured":"Kretzschmar M, Reining M. Dorsal root ganglion stimulation for treatment of central poststroke pain in the lower extremity after medullary infarction. Pain. 2021, 162:2682-5. 10.1097\/j.pain.0000000000002439","journal-title":"Pain"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1037\/a0035514","article-title":"Interdisciplinary chronic pain management: past, present, and future","volume":"69","author":"Gatchel RJ","year":"2014","unstructured":"Gatchel RJ, McGeary DD, McGeary CA, Lippe B. Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014, 69:119-30. 10.1037\/a0035514","journal-title":"Am Psychol"},{"key":"ref119","doi-asserted-by":"crossref","DOI":"10.1136\/rapm-2019-101130","article-title":"Centralized pain and pain catastrophizing mediate the association between lifetime abuse history and self-reported pain medication side effects","volume":"45","author":"Pierce J","year":"2020","unstructured":"Pierce J, Hassett AL, Schneiderhan JR, Divers J, Brummett CM, Goesling J. Centralized pain and pain catastrophizing mediate the association between lifetime abuse history and self-reported pain medication side effects. Reg Anesth Pain Med. 2020, 45:293-300.","journal-title":"Reg Anesth Pain Med"},{"key":"ref120","unstructured":"Gene therapy for chronic pain relief. (2021). Accessed. May 12, 2025: https:\/\/www.nih.gov\/news-events\/nih-research-matters\/gene-therapy-chronic-pain-relief."},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0018-1","article-title":"Current gene therapy using viral vectors for chronic pain","volume":"11","author":"Guedon JM","year":"2015","unstructured":"Guedon JM, Wu S, Zheng X, et al.. Current gene therapy using viral vectors for chronic pain. Mol Pain. 2015, 11:27. 10.1186\/s12990-015-0018-1","journal-title":"Mol Pain"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.68","article-title":"Drugging the pain epigenome","volume":"13","author":"Niederberger E","year":"2017","unstructured":"Niederberger E, Resch E, Parnham MJ, Geisslinger G. Drugging the pain epigenome. Nat Rev Neurol. 2017, 13:434-47. 10.1038\/nrneurol.2017.68","journal-title":"Nat Rev Neurol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnv088","article-title":"Correlation between DNA methylation of TRPA1 and chronic pain states in human whole blood cells","volume":"17","author":"Sukenaga N","year":"2016","unstructured":"Sukenaga N, Ikeda-Miyagawa Y, Tanada D, et al.. Correlation between DNA methylation of TRPA1 and chronic pain states in human whole blood cells. Pain Med. 2016, 17:1906-10. 10.1093\/pm\/pnv088","journal-title":"Pain Med"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.12.001","article-title":"Histone acetylation and histone deacetylation in neuropathic pain: an unresolved puzzle?","volume":"795","author":"Khangura RK","year":"2017","unstructured":"Khangura RK, Bali A, Jaggi AS, Singh N. Histone acetylation and histone deacetylation in neuropathic pain: an unresolved puzzle?. Eur J Pharmacol. 2017, 795:36-42. 10.1016\/j.ejphar.2016.12.001","journal-title":"Eur J Pharmacol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay9056","article-title":"Long-lasting analgesia via targeted in situ repression of Na(V)1.7 in mice","volume":"13","author":"Moreno AM","year":"2021","unstructured":"Moreno AM, Alem\u00e1n F, Catroli GF, et al.. Long-lasting analgesia via targeted in situ repression of Na(V)1.7 in mice. Sci Transl Med. 2021, 13:23-5. 10.1126\/scitranslmed.aay9056","journal-title":"Sci Transl Med"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417143","article-title":"The epigenetics of neuropathic pain: a systematic update","volume":"24","author":"Peth\u0151 G","year":"2023","unstructured":"Peth\u0151 G, K\u00e1nt\u00e1s B, Horv\u00e1th \u00c1, Pint\u00e9r E. The epigenetics of neuropathic pain: a systematic update. Int J Mol Sci. 2023, 24:26-8. 10.3390\/ijms242417143","journal-title":"Int J Mol Sci"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell JR","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, et al.. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017, 377:1713-22. 10.1056\/NEJMoa1706198","journal-title":"N Engl J Med"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang JH","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024, 9:78. 10.1038\/s41392-024-01780-w","journal-title":"Signal Transduct Target Ther"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.09.002","article-title":"From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function","volume":"59","author":"Greer PL","year":"2008","unstructured":"Greer PL, Greenberg ME. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron. 2008, 59:846-60. 10.1016\/j.neuron.2008.09.002","journal-title":"Neuron"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2014.55.1","article-title":"Ethical issues in pain and omics research. Some points to start the debate","volume":"55","author":"Compagnone C","year":"2014","unstructured":"Compagnone C, Tagliaferri F, Allegri M, Fanelli G. Ethical issues in pain and omics research. Some points to start the debate. Croat Med J. 2014, 55:1-2. 10.3325\/cmj.2014.55.1","journal-title":"Croat Med J"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1177\/17470161221131497","article-title":"Overcoming barriers to informed consent in neurological research: perspectives from a national survey","volume":"19","author":"Sankary LR","year":"2023","unstructured":"Sankary LR, Zelinsky ME, Ford PJ, Blackstone EC, Fox RJ. Overcoming barriers to informed consent in neurological research: perspectives from a national survey. Res Ethics. 2023, 19:42-61. 10.1177\/17470161221131497","journal-title":"Res Ethics"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-720x.2000.tb00315.x","article-title":"Involving study populations in the review of genetic research","volume":"28","author":"Sharp RR","year":"2000","unstructured":"Sharp RR, Foster MW. Involving study populations in the review of genetic research. J Law Med Ethics. 2000, 28:41-51. 10.1111\/j.1748-720x.2000.tb00315.x","journal-title":"J Law Med Ethics"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi F","year":"2013","unstructured":"Mingozzi F, High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood. 2013, 122:23-36. 10.1182\/blood-2013-01-306647","journal-title":"Blood"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack DW","year":"2005","unstructured":"Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 2005, 4:581-93. 10.1038\/nrd1775","journal-title":"Nat Rev Drug Discov"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj0901009","article-title":"Nonviral gene delivery: what we know and what is next","volume":"9","author":"Gao X","year":"2007","unstructured":"Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J. 2007, 9:E92-104. 10.1208\/aapsj0901009","journal-title":"AAPS J"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36197","article-title":"Gene Therapy for Spinal Muscular Atrophy (SMA): A Review of Current Challenges and Safety Considerations for onasemnogene abeparvovec (Zolgensma)","volume":"15","author":"Ogbonmide T","year":"2023","unstructured":"Ogbonmide T, Rathore R, Rangrej SB, et al.. Gene Therapy for Spinal Muscular Atrophy (SMA): A Review of Current Challenges and Safety Considerations for onasemnogene abeparvovec (Zolgensma). Cureus. 2023, 15:e36197. 10.7759\/cureus.36197","journal-title":"Cureus"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1126\/science.1091258","article-title":"Medicine. Gene therapy--new challenges ahead","volume":"302","author":"Williams DA","year":"2003","unstructured":"Williams DA, Baum C. Medicine. Gene therapy--new challenges ahead. Science. 2003, 302:400-1. 10.1126\/science.1091258","journal-title":"Science"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn DB","year":"2023","unstructured":"Kohn DB, Chen YY, Spencer MJ. Successes and challenges in clinical gene therapy. Gene Ther. 2023, 30:738-46. 10.1038\/s41434-023-00390-5","journal-title":"Gene Ther"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01310.x","article-title":"Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States","volume":"13","author":"Meghani SH","year":"2012","unstructured":"Meghani SH, Byun E, Gallagher RM. Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med. 2012, 13:150-74. 10.1111\/j.1526-4637.2011.01310.x","journal-title":"Pain Med"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2016.162","article-title":"Structural plasticity and reorganisation in chronic pain","volume":"18","author":"Kuner R","year":"2016","unstructured":"Kuner R, Flor H. Structural plasticity and reorganisation in chronic pain. Nat Rev Neurosci. 2016, 18:20-30. 10.1038\/nrn.2016.162","journal-title":"Nat Rev Neurosci"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000207","article-title":"What do monoamines do in pain modulation?","volume":"10","author":"Bannister K","year":"2016","unstructured":"Bannister K, Dickenson AH. What do monoamines do in pain modulation?. Curr Opin Support Palliat Care. 2016, 10:143-8. 10.1097\/SPC.0000000000000207","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1578138","article-title":"CRISPR\/Cas9-Based therapeutics as a promising strategy for management of Alzheimer's disease: progress and prospects","volume":"19","author":"Khan MS","year":"2025","unstructured":"Khan MS, Qureshi N, Khan R, Son YO, Maqbool T. CRISPR\/Cas9-Based therapeutics as a promising strategy for management of Alzheimer's disease: progress and prospects. Front Cell Neurosci. 2025, 19:1578138. 10.3389\/fncel.2025.1578138","journal-title":"Front Cell Neurosci"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3308","article-title":"Transcriptional regulator PRDM12 is essential for human pain perception","volume":"47","author":"Chen YC","year":"2015","unstructured":"Chen YC, Auer-Grumbach M, Matsukawa S, et al.. Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet. 2015, 47:803-8. 10.1038\/ng.3308","journal-title":"Nat Genet"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0905859106","article-title":"Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection","volume":"106","author":"Kantor B","year":"2009","unstructured":"Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci U S A. 2009, 106:18786-91. 10.1073\/pnas.0905859106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-65","article-title":"DNA methylation of SPARC and chronic low back pain","volume":"7","author":"Tajerian M","year":"2011","unstructured":"Tajerian M, Alvarado S, Millecamps M, et al.. DNA methylation of SPARC and chronic low back pain. Mol Pain. 2011, 7:65. 10.1186\/1744-8069-7-65","journal-title":"Mol Pain"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.11.022","article-title":"Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review","volume":"79","author":"Turecki G","year":"2016","unstructured":"Turecki G, Meaney MJ. Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review. Biol Psychiatry. 2016, 79:87-96. 10.1016\/j.biopsych.2014.11.022","journal-title":"Biol Psychiatry"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2008.09.018","article-title":"Towards a theory of chronic pain","volume":"87","author":"Apkarian AV","year":"2009","unstructured":"Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol. 2009, 87:81-97. 10.1016\/j.pneurobio.2008.09.018","journal-title":"Prog Neurobiol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.04.041","article-title":"Genetic predictors of human chronic pain conditions","volume":"338","author":"Zorina-Lichtenwalter K","year":"2016","unstructured":"Zorina-Lichtenwalter K, Meloto CB, Khoury S, Diatchenko L. Genetic predictors of human chronic pain conditions. Neuroscience. 2016, 338:36-62. 10.1016\/j.neuroscience.2016.04.041","journal-title":"Neuroscience"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.04.009","article-title":"Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography","volume":"39","author":"Kwon JM","year":"2020","unstructured":"Kwon JM, Kim KH, Medina-Inojosa J, Jeon KH, Park J, Oh BH. Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography. J Heart Lung Transplant. 2020, 39:805-14. 10.1016\/j.healun.2020.04.009","journal-title":"J Heart Lung Transplant"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2015.01.003","article-title":"The common link between functional somatic syndromes may be central sensitisation","volume":"78","author":"Bourke JH","year":"2015","unstructured":"Bourke JH, Langford RM, White PD. The common link between functional somatic syndromes may be central sensitisation. J Psychosom Res. 2015, 78:228-36. 10.1016\/j.jpsychores.2015.01.003","journal-title":"J Psychosom Res"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302611","article-title":"Health care disparities in the post-Affordable Care Act era","volume":"105","author":"Adepoju OE","year":"2015","unstructured":"Adepoju OE, Preston MA, Gonzales G. Health care disparities in the post-Affordable Care Act era. Am J Public Health. 2015, 105:S665-7. 10.2105\/AJPH.2015.302611","journal-title":"Am J Public Health"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision medicine: from science to value","volume":"37","author":"Ginsburg GS","year":"2018","unstructured":"Ginsburg GS, Phillips KA. Precision medicine: from science to value. Health Aff (Millwood). 2018, 37:694-701. 10.1377\/hlthaff.2017.1624","journal-title":"Health Aff (Millwood)"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2017.06.012","article-title":"Human germline genome editing","volume":"101","author":"Ormond KE","year":"2017","unstructured":"Ormond KE, Mortlock DP, Scholes DT, et al.. Human germline genome editing. Am J Hum Genet. 2017, 101:167-76. 10.1016\/j.ajhg.2017.06.012","journal-title":"Am J Hum Genet"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201541337","article-title":"No time to waste--the ethical challenges created by CRISPR: CRISPR\/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells","volume":"16","author":"Caplan AL","year":"2015","unstructured":"Caplan AL, Parent B, Shen M, Plunkett C. No time to waste--the ethical challenges created by CRISPR: CRISPR\/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells. EMBO Rep. 2015, 16:1421-6. 10.15252\/embr.201541337","journal-title":"EMBO Rep"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-061010-113817","article-title":"The development and application of optogenetics","volume":"34","author":"Fenno L","year":"2011","unstructured":"Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annu Rev Neurosci. 2011, 34:389-412. 10.1146\/annurev-neuro-061010-113817","journal-title":"Annu Rev Neurosci"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett CF","year":"2019","unstructured":"Bennett CF. Therapeutic antisense oligonucleotides are coming of age. Annu Rev Med. 2019, 70:307-21. 10.1146\/annurev-med-041217-010829","journal-title":"Annu Rev Med"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S179152","article-title":"Update on the pharmacogenomics of pain management","volume":"12","author":"Kaye AD","year":"2019","unstructured":"Kaye AD, Garcia AJ, Hall OM, et al.. Update on the pharmacogenomics of pain management. Pharmgenomics Pers Med. 2019, 12:125-43. 10.2147\/PGPM.S179152","journal-title":"Pharmgenomics Pers Med"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162613","article-title":"Role of epigenetic mechanisms in chronic pain","volume":"11","author":"Mauceri D","year":"2022","unstructured":"Mauceri D. Role of epigenetic mechanisms in chronic pain. Cells. 2022, 11:16-8. 10.3390\/cells11162613","journal-title":"Cells"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417083-gene-therapy-and-epigenetic-modulation-in-chronic-pain-a-future-without-opioids","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T03:35:37Z","timestamp":1760412937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417083-gene-therapy-and-epigenetic-modulation-in-chronic-pain-a-future-without-opioids"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":158,"URL":"https:\/\/doi.org\/10.7759\/cureus.94508","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}